肝孤立性纤维瘤1例报告
DOI: 10.3969/j.issn.1001-5256.2022.03.026
伦理学声明:本例报告已获得患者知情同意。
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:李学成负责拟定写作思路,撰写论文; 范莹负责课题设计,指导撰写论文; 吴硕东负责指导撰写文章并最后定稿。
-
-
Key words:
- Liver Neoplasms /
- Solitary Fibrous Tumors /
- Diagnosis
-
[1] NAM HC, SUNG PS, JUNG ES, et al. Solitary fibrous tumor of the liver mimicking malignancy[J]. Korean J Intern Med, 2020, 35(3): 734-735. DOI: 10.3904/kjim.2018.442. [2] ANDALUZ GARCÍA I, TAVECCHIA M, OLVEIRA MARTÍN A. A solitary fibrous tumor: An entity to consider in the diagnosis of liver masses[J]. Rev Esp Enferm Dig, 2019, 111(12): 969. DOI: 10.17235/reed.2019.6433/2019. [3] ROUY M, GUILBAUD T, BIRNBAUM DJ. Liver solitary fibrous tumor: A rare incidentaloma[J]. J Gastrointest Surg, 2021, 25(3): 852-853. DOI: 10.1007/s11605-020-04701-8. [4] ALONSO BATANERO S, GARROSA MUÑOZ S, IGLESIAS IGLESIAS MJ, et al. A giant solitary fibrous tumor arising from the hepatic round ligament[J]. Dig Liver Dis, 2021, 53(3): 379-380. DOI: 10.1016/j.dld.2020.06.015. [5] DU Y, YAN YH, XIAO JS, et al. Giant right hepatic benign fibroma: A case report and literature review[J]. Chin J Hepatobiliary Surg, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016.杜源, 鄢业鸿, 肖建生, 等. 右肝巨大纤维瘤一例并文献复习[J]. 中华肝胆外科杂志, 2019, 25(9): 701-702. DOI: 10.3760/cma.j.issn.1007-8118.2019.09.016. [6] MU YP, WANG RT, HOU HL, et al. Clinicopathological characteristics and surgical effcacy of liver solitary fibrous tumor and literature review[J/CD]. Chin J Hepat Surg (Electronic Edition), 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019.牟怡平, 王瑞涛, 侯惠莲, 等. 肝脏孤立性纤维瘤临床病理特征及手术疗效并文献复习[J/CD]. 中华肝脏外科手术学电子杂志, 2021, 10(1): 87-92. DOI: 10.3877/cma.j.issn.2095-3232.2021.01.019. [7] FAMÀ F, LE BOUC Y, BARRANDE G, et al. Solitary fibrous tumour of the liver with IGF-Ⅱ-related hypoglycaemia. A case report[J]. Langenbecks Arch Surg, 2008, 393(4): 611-616. DOI: 10.1007/s00423-008-0329-z. [8] VENNARECCI G, ETTORRE GM, GIOVANNELLI L, et al. Solitary fibrous tumor of the liver[J]. J Hepatobiliary Pancreat Surg, 2005, 12(4): 341-344. DOI: 10.1007/s00534-005-0993-0. [9] DELVECCHIO A, DUDA L, CONTICCHIO M, et al. Doege-Potter syndrome by malignant solitary fibrous tumor of the liver: A case report and review of literature[J]. World J Gastrointest Surg, 2019, 11(8): 348-357. DOI: 10.4240/wjgs.v11.i8.348. [10] SONG L, ZHANG W, ZHANG Y. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor[J]. Clin Nucl Med, 2014, 39(7): 662-664. DOI: 10.1097/RLU.0000000000000431. [11] DOYLE LA, VIVERO M, FLETCHER CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics[J]. Mod Pathol, 2014, 27(3): 390-395. DOI: 10.1038/modpathol.2013.164. [12] YOSHIDA A, TSUTA K, OHNO M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors[J]. Am J Surg Pathol, 2014, 38(4): 552-559. DOI: 10.1097/PAS.0000000000000137. [13] DEMICCO EG, HARMS PW, PATEL RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors[J]. Am J Clin Pathol, 2015, 143(5): 672-682. DOI: 10.1309/AJCPN25NJTOUNPNF. [14] O'NEILL AC, TIRUMANI SH, DO WS, et al. Metastatic patterns of solitary fibrous tumors: A single-institution experience[J]. AJR Am J Roentgenol, 2017, 208(1): 2-9. DOI: 10.2214/AJR.16.16662. [15] EBATA T, SHIMOI T, BUN S, et al. Efficacy and safety of pazopanib for recurrent or metastatic solitary fibrous tumor[J]. Oncology, 2018, 94(6): 340-344. DOI: 10.1159/000486623. [16] MARUZZO M, MARTIN-LIBERAL J, MESSIOU C, et al. Pazopanib as first line treatment for solitary fibrous tumours: The Royal Marsden Hospital experience[J]. Clin Sarcoma Res, 2015, 5: 5. DOI: 10.1186/s13569-015-0022-2. [17] STACCHIOTTI S, TORTORETO M, BALDI GG, et al. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour[J]. Eur J Cancer, 2014, 50(17): 3021-3028. DOI: 10.1016/j.ejca.2014.09.004.